Tempest Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-9.2M | $-8.5M | $-28.3M | $-8.1M | $-7.1M | $-5.4M | $3.5M | $-5.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $112.0K | $108.0K | $103.0K | $107.0K | $86.0K | $78.0K | $141.0K | $81.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-8.4M | $-7.1M | $-8.0M | $-11.8M | $127.0K | $-6.3M | $-4.3M | $-4.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $95.0K | $3.0K | $27.0K | $24.0K | $70.0K | $14.0K | $5.0K | $8.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-95.0K | $-3.0K | $-27.0K | $14.0K | $-70.0K | $-14.0K | $-5.0K | $-8.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $14.4M | $1.4M | $-9.0K | $3.2M | $41.0M | $14.9M | $30.0K | $11.0K |
| Net Change in Cash | $5.9M | $-5.7M | — | — | — | $-11.8M | $-44.7M | $32.3M |
| Free Cash Flow | $-8.5M | $-7.1M | $-8.0M | $-11.8M | $57.0K | $-6.3M | $-4.3M | $-4.6M |